Ana Pedrero Gil: Navigating Anemia Management in Patients With Stroke or Malignancy History
Ana Pedrero Gil, Anesthesiologist at Igualada University Hospital, shared a post on LinkedIn, about a recent article by Rammdeep Saini, published in Canadian Journal of Kidney Health and Disease, adding:
“Erythropoiesis-stimulating agents (ESAs) are commonly used to manage chronic kidney disease (CKD) associated anemia.
There is a paucity of clear guidelines on their use in patients with CKD and with history of stroke or malignancy.”
Title: A Canadian Survey of Prescribing Practices of Erythropoiesis-Stimulating Agents in Dialysis-Dependent and Non-Dialysis-Dependent Chronic Kidney Disease
Authors: Rammdeep Saini, Keigan More, Jo-Anne S. Wilson, David A. Clark, Amanda J. Vinson, David Collister, Mark Canney, and Karthik K. Tennankore
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 21:47Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention
-
Sep 29, 2026, 22:26A Global Call for Action on Cardiovascular Health on World Heart Day – ISTH